Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response
Authors
Keywords
Drug metabolism, Blood plasma, Opioids, Enzyme metabolism, Genetic polymorphism, Alleles, Drug therapy, Variant genotypes
Journal
PLoS One
Volume 6, Issue 5, Pages e19527
Publisher
Public Library of Science (PLoS)
Online
2011-05-13
DOI
10.1371/journal.pone.0019527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interindividual Variability of Methadone Response
- (2012) Yongfang Li et al. Molecular Diagnosis & Therapy
- Polymorphism of the μ-Opioid Receptor Gene (OPRM1 118A>G) Affects Fentanyl-Induced Analgesia During Anesthesia and Recovery
- (2012) Wei Dong Wu et al. Molecular Diagnosis & Therapy
- CYP2B6 and OPRM1 gene variations predict methadone-related deaths
- (2010) Hannah Bunten et al. ADDICTION BIOLOGY
- Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip™
- (2010) Elisabet Cuyàs et al. PHARMACOGENOMICS
- Role of CYP2B6 in Stereoselective Human Methadone Metabolism
- (2009) Rheem A. Totah et al. ANESTHESIOLOGY
- kappa-Opioid receptor signaling and brain reward function
- (2009) Adrie W. Bruijnzeel BRAIN RESEARCH REVIEWS
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- (2009) Shu-Feng Zhou CLINICAL PHARMACOKINETICS
- Methadone-Nicotine Interactions in Methadone Maintenance Treatment Patients
- (2009) Alexander K. Elkader et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Major Depressive Disorder and Patient Satisfaction in Relation to Methadone Pharmacokinetics and Pharmacodynamics in Stabilized Methadone Maintenance Patients
- (2009) Alexander K. Elkader et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution
- (2009) Alexandra Doehring et al. Pharmacogenetics and Genomics
- Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment
- (2008) Mohammad-Reza Shiran et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Value of CYP2D6 and OPRM1 Pharmacogenetic Testing for Opioid Therapy
- (2008) Kristen K. Reynolds et al. CLINICS IN LABORATORY MEDICINE
- CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme
- (2008) Hongbing Wang et al. CURRENT DRUG METABOLISM
- Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency
- (2008) David H. Epstein et al. DRUG AND ALCOHOL DEPENDENCE
- ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
- (2008) Orna Levran et al. HUMAN MOLECULAR GENETICS
- Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment
- (2008) Amandeep Mann et al. NEUROPHARMACOLOGY
- Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
- (2008) Séverine Crettol et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates
- (2008) Colin N. Haile et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement
- (2007) S Crettol et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search